Chemotherapy News and Research

Latest Chemotherapy News and Research

Chemotherapy Patients Benefit from Optimum Coolant Flow During Treatment

Titan Enterprises celebrates over 10 years of partnership development with Paxman Coolers Ltd (www.paxmanscalpcooling.com) as the company reports over 4,000 Paxman scalp-cooling systems are now installed around the world, reducing the likelihood of chemotherapy-induced alopecia.

From Titan Enterprises Ltd 15 Oct 2021

Ondansetron use associated with increased survival in mechanically ventilated COVID-19 patients

A recent study analyzes real-world data using artificial intelligence to provide insights into using ondansetron, an antiemetic agent, among SARS-CoV-2 positive patients.

14 Oct 2021

MR-guided focused ultrasound can safely deliver antibody therapy to Her2-positive brain metastases

In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto, Canada, have demonstrated that magnetic resonance (MR)-guided focused ultrasound can be used to safely deliver antibody therapy to breast cancer that has metastasized to the brain.

13 Oct 2021

Study shows how tissue-derived T cells can damage other organs in stem cell transplant patients

More than 40,000 allogeneic hematopoietic stem cell transplants are carried out worldwide every year, mostly for patients suffering from leukemia or other diseases of the hematopoietic system.

13 Oct 2021

Wyss Center to lead a collaborative project aimed at improving brain cancer treatment

The Wyss Center announced today that it will lead a collaborative project, as part of Wellcome Leap's Delta Tissue Program, to improve understanding of the brain cancer glioblastoma (GBM) and help develop more effective therapies.

8 Oct 2021

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021.

7 Oct 2021

Scientists identify a new method to treat triple-negative breast cancer

A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) and A*STAR's Genome Institute of Singapore (GIS) has identified a novel method to treat triple-negative breast cancer (TNBC). They discovered that cancer cells switch between different cell states and are able to change from being less aggressive ('epithelial') to being more aggressive ('mesenchymal'), and vice versa.

7 Oct 2021

Pancreatic cancer clinical trials exclude Black patients based on wide range of eligibility criteria

A simulated pancreatic cancer clinical trial screening process showed that Black patients were significantly more likely than white patients to be excluded from clinical trials for a wide range of eligibility criteria, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.

6 Oct 2021

Psychological therapy alleviates adverse biobehavioral effects in young adult testicular cancer survivors

Psychological therapy reduces the adverse biobehavioral effects of testicular cancer in young adult survivors, according to a pilot study led by the University of California, Irvine.

6 Oct 2021

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.

6 Oct 2021

New mathematical modeling technique can accurately predict tumor response to chemotherapy

A public/private collaboration led by researchers at The University of Texas at Austin has resulted in a new mathematical modeling technique that can accurately predict the response of tumors in breast cancer patients to treatments such as chemotherapy soon after treatment initiation.

5 Oct 2021

Northwestern’s SPORE has made advances in understanding the genetic basis of glioblastoma

Glioblastoma is one of the deadliest cancers known to man. While the advent of immunotherapy and other cutting-edge treatments have prolonged life for people afflicted with other types of cancer, the prognosis for glioblastoma has remained relatively constant: just 18 months.

3 Oct 2021

Osimertinib offers a hint of added benefit for NSCLC patients who have received adjuvant chemotherapy

Osimertinib was the first drug to be approved for adjuvant treatment after complete tumour resection in adults with stage IB to IIIA non-small cell lung cancer (NSCLC).

2 Oct 2021

Cancer patients on chemotherapy have lower immune response to COVID-19 vaccine, study finds

The COVID-19 pandemic has been an especially stressful time for cancer patients undergoing chemotherapy, which attacks not only the cancer, but also the immune cells needed to defend the body from infections.

2 Oct 2021

WHO's new List of Essential Medicines prioritizes access to diabetes and cancer treatments

WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials to treat serious bacterial and fungal infections.

1 Oct 2021

Novel Assay Platform for 3D Microfluidic Cancer Research

AMSBIO have supplied custom Chimeric antigen receptor (CAR)-T products to the University of Strathclyde (UoS) in Glasgow, UK, and ScreenIn3D Ltd, allowing them to perform novel immune-oncology assays in 3D microfluidic cancer models.

From AMS Biotechnology 1 Oct 2021

Additional supportive care services benefit older adults receiving chemotherapy, study finds

A clinical trial led by researchers at City of Hope, a world-renowned cancer research and treatment organization, showed that patients over 65 receiving chemotherapy experienced significantly fewer treatment-related side effects when a multidisciplinary team of experts analyzed each case and introduced personalized interventions.

30 Sep 2021

Research points the way to identifying new precision treatments for cancer

Researchers at University of California San Diego and University of California San Francisco have mapped out how hundreds of mutations involved in two types of cancer affect the activity of discrete groups of proteins that are the ultimate actors behind the disease.

30 Sep 2021

New AI-based tool improves the diagnosis of breast cancer tumors

Researchers at Karolinska Institutet in Sweden have developed an AI-based tool that improves the diagnosis of breast cancer tumors and the ability to predict the risk of recurrence.

30 Sep 2021

New SBIR award helps Temple scientists to explore the therapeutic potential of novel cannabis analog

More than 20 percent of adults in the United States live with chronic pain. For many affected individuals, long-term physical discomfort negatively impacts overall well-being, leading to reduced work output and increased anxiety and depression.

29 Sep 2021

Chemotherapy News and Research

Latest Chemotherapy News and Research

Chemotherapy Patients Benefit from Optimum Coolant Flow During Treatment

Ondansetron use associated with increased survival in mechanically ventilated COVID-19 patients

MR-guided focused ultrasound can safely deliver antibody therapy to Her2-positive brain metastases

Study shows how tissue-derived T cells can damage other organs in stem cell transplant patients

Wyss Center to lead a collaborative project aimed at improving brain cancer treatment

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

Scientists identify a new method to treat triple-negative breast cancer

Pancreatic cancer clinical trials exclude Black patients based on wide range of eligibility criteria

Psychological therapy alleviates adverse biobehavioral effects in young adult testicular cancer survivors

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

New mathematical modeling technique can accurately predict tumor response to chemotherapy

Northwestern’s SPORE has made advances in understanding the genetic basis of glioblastoma

Osimertinib offers a hint of added benefit for NSCLC patients who have received adjuvant chemotherapy

Cancer patients on chemotherapy have lower immune response to COVID-19 vaccine, study finds

WHO's new List of Essential Medicines prioritizes access to diabetes and cancer treatments

Novel Assay Platform for 3D Microfluidic Cancer Research

Additional supportive care services benefit older adults receiving chemotherapy, study finds

Research points the way to identifying new precision treatments for cancer

New AI-based tool improves the diagnosis of breast cancer tumors

New SBIR award helps Temple scientists to explore the therapeutic potential of novel cannabis analog

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in